Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds

Antimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The globa...

Full description

Bibliographic Details
Main Authors: Andrea Barbieri Barros, Alex Miranda Rodrigues, Mariane Pereira Batista, Sidney Munhoz Junior, Marcia Hueb, Cor Jesus Fontes
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2014-07-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762014000400499&lng=en&tlng=en
_version_ 1797757085805445120
author Andrea Barbieri Barros
Alex Miranda Rodrigues
Mariane Pereira Batista
Sidney Munhoz Junior
Marcia Hueb
Cor Jesus Fontes
author_facet Andrea Barbieri Barros
Alex Miranda Rodrigues
Mariane Pereira Batista
Sidney Munhoz Junior
Marcia Hueb
Cor Jesus Fontes
author_sort Andrea Barbieri Barros
collection DOAJ
description Antimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The global incidence of herpes zoster is approximately 2.5 cases per 1,000 persons per month (or 30 cases per 1,000 persons per year). The estimated incidence of herpes zoster in patients undergoing antimony therapy is higher than previously reported.
first_indexed 2024-03-12T18:10:53Z
format Article
id doaj.art-040b362243b744f889b2af50daf0ea3c
institution Directory Open Access Journal
issn 1678-8060
language English
last_indexed 2024-03-12T18:10:53Z
publishDate 2014-07-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-040b362243b744f889b2af50daf0ea3c2023-08-02T09:15:31ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz1678-80602014-07-01109449950110.1590/0074-0276130563S0074-02762014000400499Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compoundsAndrea Barbieri BarrosAlex Miranda RodriguesMariane Pereira BatistaSidney Munhoz JuniorMarcia HuebCor Jesus FontesAntimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The global incidence of herpes zoster is approximately 2.5 cases per 1,000 persons per month (or 30 cases per 1,000 persons per year). The estimated incidence of herpes zoster in patients undergoing antimony therapy is higher than previously reported.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762014000400499&lng=en&tlng=enleishmaniasisherpes zosterantimony therapy
spellingShingle Andrea Barbieri Barros
Alex Miranda Rodrigues
Mariane Pereira Batista
Sidney Munhoz Junior
Marcia Hueb
Cor Jesus Fontes
Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
Memorias do Instituto Oswaldo Cruz
leishmaniasis
herpes zoster
antimony therapy
title Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title_full Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title_fullStr Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title_full_unstemmed Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title_short Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title_sort varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
topic leishmaniasis
herpes zoster
antimony therapy
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762014000400499&lng=en&tlng=en
work_keys_str_mv AT andreabarbieribarros varicellazostervirusreactivationduringorimmediatelyfollowingtreatmentoftegumentaryleishmaniasiswithantimonycompounds
AT alexmirandarodrigues varicellazostervirusreactivationduringorimmediatelyfollowingtreatmentoftegumentaryleishmaniasiswithantimonycompounds
AT marianepereirabatista varicellazostervirusreactivationduringorimmediatelyfollowingtreatmentoftegumentaryleishmaniasiswithantimonycompounds
AT sidneymunhozjunior varicellazostervirusreactivationduringorimmediatelyfollowingtreatmentoftegumentaryleishmaniasiswithantimonycompounds
AT marciahueb varicellazostervirusreactivationduringorimmediatelyfollowingtreatmentoftegumentaryleishmaniasiswithantimonycompounds
AT corjesusfontes varicellazostervirusreactivationduringorimmediatelyfollowingtreatmentoftegumentaryleishmaniasiswithantimonycompounds